Clinical trial / 2012
Lactobacillus plantarum 299v improved abdominal pain and bloating in irritable bowel syndrome.
In a double-blind, randomized trial, 214 patients with irritable bowel syndrome received one capsule daily of Lactobacillus plantarum 299v (DSM 9843) or placebo for 4 weeks. After 4 weeks, pain severity (0.68 ± 0.53 vs 0.92 ± 0.57, P < 0.05) and pain frequency (1.01 ± 0.77 vs 1.71 ± 0.93, P < 0.05) were significantly lower with the probiotic than placebo, with similar benefits noted for bloating. An excellent or good symptomatic response was reported by 78.1% of the probiotic group versus 8.1% of the placebo group (P < 0.01).
- Study type
- Randomized controlled trial
- Who was studied
- 214 patients with irritable bowel syndrome meeting Rome III criteria
- What was measured
- Abdominal pain severity and frequency, bloating, and overall symptom relief
THE PAPER
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
Ducrotté P, Sawant P, Jayanthi V. World J Gastroenterol, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.